DK0637966T3 - Tumoricid terapi med "tilskuer-virkning" - Google Patents

Tumoricid terapi med "tilskuer-virkning"

Info

Publication number
DK0637966T3
DK0637966T3 DK93910880.9T DK93910880T DK0637966T3 DK 0637966 T3 DK0637966 T3 DK 0637966T3 DK 93910880 T DK93910880 T DK 93910880T DK 0637966 T3 DK0637966 T3 DK 0637966T3
Authority
DK
Denmark
Prior art keywords
tumor
replication
transformed
competent
treatment
Prior art date
Application number
DK93910880.9T
Other languages
Danish (da)
English (en)
Inventor
R Michael Blaese
Kenneth W Culver
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of DK0637966T3 publication Critical patent/DK0637966T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK93910880.9T 1992-05-01 1993-05-03 Tumoricid terapi med "tilskuer-virkning" DK0637966T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87751992A 1992-05-01 1992-05-01

Publications (1)

Publication Number Publication Date
DK0637966T3 true DK0637966T3 (da) 1998-05-04

Family

ID=25370142

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93910880.9T DK0637966T3 (da) 1992-05-01 1993-05-03 Tumoricid terapi med "tilskuer-virkning"

Country Status (11)

Country Link
US (1) US6045789A (fr)
EP (1) EP0637966B1 (fr)
JP (1) JPH07506370A (fr)
AT (1) ATE157261T1 (fr)
AU (1) AU675948B2 (fr)
CA (1) CA2134763A1 (fr)
DE (1) DE69313443T2 (fr)
DK (1) DK0637966T3 (fr)
ES (1) ES2110091T3 (fr)
GR (1) GR3025493T3 (fr)
WO (1) WO1993021959A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040063652A1 (en) * 1988-03-21 2004-04-01 Jolly Douglas J. Combination gene delivery vehicles
US5716826A (en) 1988-03-21 1998-02-10 Chiron Viagene, Inc. Recombinant retroviruses
US5662896A (en) * 1988-03-21 1997-09-02 Chiron Viagene, Inc. Compositions and methods for cancer immunotherapy
US6241982B1 (en) 1988-03-21 2001-06-05 Chiron Corporation Method for treating brain cancer with a conditionally lethal gene
US6569679B1 (en) 1988-03-21 2003-05-27 Chiron Corporation Producer cell that generates adenoviral vectors encoding a cytokine and a conditionally lethal gene
US6133029A (en) * 1988-03-21 2000-10-17 Chiron Corporation Replication defective viral vectors for infecting human cells
US6337209B1 (en) 1992-02-26 2002-01-08 Glaxo Wellcome Inc. Molecular constructs containing a carcinoembryonic antigen regulatory sequence
US6555370B1 (en) 1990-11-13 2003-04-29 Immunex Corporation Bifunctional selectable fusion genes
US5529774A (en) 1991-08-13 1996-06-25 The Regents Of The University Of California In vivo transfer of the HSV-TK gene implanted retroviral producer cells
FR2699082B1 (fr) * 1993-02-22 1995-05-05 Pasteur Institut Composition pour le traitement de tumeurs et l'immunisation d'organismes à l'encontre de tumeurs.
CA2163427A1 (fr) * 1993-05-21 1994-12-08 Stephen D. Lupton Genes hybrides bifonctionnels selectables, a base du gene de la cytosine desaminase (cd)
US5631236A (en) 1993-08-26 1997-05-20 Baylor College Of Medicine Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
CA2173495A1 (fr) * 1993-10-06 1995-04-13 Kenneth W. Culver Traitement de tumeurs par la transformation genetique des cellules tumorales a l'aide de genes codants des marqueurs selectifs negatifs et des cytokines
CA2158936C (fr) * 1993-11-18 2012-02-21 Jack R. Barber Compositions et procedes d'utilisation de genes a pouvoir letal conditionnel
AU2434195A (en) * 1994-05-02 1995-11-29 University Of Washington Thymidine kinase mutants
US6451571B1 (en) 1994-05-02 2002-09-17 University Of Washington Thymidine kinase mutants
DE4431401A1 (de) * 1994-08-24 1996-02-29 Max Delbrueck Centrum Lebendvakzine gegen Tumorerkrankungen
JP3822261B2 (ja) * 1994-09-09 2006-09-13 財団法人癌研究会 癌の遺伝子治療剤
FR2725213B1 (fr) * 1994-10-04 1996-11-08 Rhone Poulenc Rorer Sa Vecteurs viraux et utilisation en therapie genique
US20020115213A1 (en) * 1998-08-14 2002-08-22 Northeastern Ohio Universities Of Medicine Engraftable neural progenitor & stem cells for brain tumor therapy
US7005126B1 (en) * 1999-06-08 2006-02-28 Human Gene Therapy Research Institute Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effect
DE19928342A1 (de) * 1999-06-21 2000-12-28 Deutsches Krebsforsch Vektoren zur gentherapeutischen Tumorbehandlung
KR100601982B1 (ko) 2005-01-20 2006-07-18 삼성전자주식회사 흡열반응을 통한 가열-냉각 과정에 의한 세포 용해 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0454781B1 (fr) * 1989-01-23 1998-12-16 Chiron Corporation Cellules de recombinaison pour des therapies d'infections et de troubles hyperproliferatifs et la preparation de ces cellules
CA2051288C (fr) * 1990-09-14 2002-02-05 Robert L. Martuza Destruction ciblee de cellules neoplasiques par un virus
DE69114299T3 (de) * 1990-09-14 2005-09-15 The Johns Hopkins University Verfahren und zusammensetzungen für gentherapie und stärkung des immunsystems.
US5358866A (en) * 1991-07-03 1994-10-25 The United States Of America As Represented By The Department Of Health And Human Services Cytosine deaminase negative selection system for gene transfer techniques and therapies
JPH06509578A (ja) * 1991-07-26 1994-10-27 ユニバーシティ・オブ・ロチェスター 悪性細胞利用による癌治療法
US5529774A (en) * 1991-08-13 1996-06-25 The Regents Of The University Of California In vivo transfer of the HSV-TK gene implanted retroviral producer cells
ATE237694T1 (de) * 1991-08-20 2003-05-15 Us Gov Health & Human Serv Adenovirus vermittelter gentransfer in den gastrointestinaltrakt

Also Published As

Publication number Publication date
AU675948B2 (en) 1997-02-27
US6045789A (en) 2000-04-04
GR3025493T3 (en) 1998-02-27
JPH07506370A (ja) 1995-07-13
DE69313443T2 (de) 1998-03-19
ATE157261T1 (de) 1997-09-15
WO1993021959A1 (fr) 1993-11-11
CA2134763A1 (fr) 1993-11-11
DE69313443D1 (de) 1997-10-02
ES2110091T3 (es) 1998-02-01
EP0637966B1 (fr) 1997-08-27
EP0637966A1 (fr) 1995-02-15
AU4221793A (en) 1993-11-29

Similar Documents

Publication Publication Date Title
DK0637966T3 (da) Tumoricid terapi med "tilskuer-virkning"
EP0584266A4 (fr) Antigene carcino-embryonnaire exprimant un virus recombine et ses procedes d'utilisation.
AU588806B2 (en) Drug, and methods of preparing and using it for treatment of tumors
DE68921918D1 (de) Verfahren zur Voraussage der Wirksamkeit einer antineoplastichen Behandlung bei einzelnen Patienten.
IT8419266A0 (it) Tessuti del corpo umano e dispositivo per generare calore in procedimento di generazione dicalore, particolarmente per la cura di tumori.
FI914427A0 (fi) Expression av exogena polynukleotid- sekvenser i ett ryggradsdjur.
HK1010790A1 (en) Adheson variants
EP0210351A3 (en) Use of porphyrin derivatives in the detection and treatment of tumours
CA2118724A1 (fr) Methode de detection des genes c-raf-1
ES2001875A6 (es) Procedimiento para preparar nuevos derivados de aminoacidos
AU5318496A (en) Adenovirus vectors for gene therapy
NO932101L (no) Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker
EP0057209A4 (fr) Nouvelle preparation d'acide amine et therapie pour le traitement du "stress" et des blessures.
AU4908385A (en) Priming and purging blood treatment apparatus
EP0684831A4 (fr) Vaccin allogene et procede de synthese de ce vaccin.
IT8847622A0 (it) Zi procedimento ed apparecchio per il trattamento elettrochimico di pez-
ES8502437A1 (es) Procedimiento para la obtencion del 1-(2,3-dihidro-1,4-benzodioxin-2s-il)-5-(2,3-dihidro-1,4-benzodioxin-2r-il)-3-azapentan-1r-5s-diol.
AU1933588A (en) Treatment of malignant tumors with 8-aminoadenosine 3',5'-cyclic phosphate and combinations of 8-aminoadeno- sine 3',5'-cyclic phosphate and 8-chloroadenosine 3',5'- cyclic phosphate
IT8721683A0 (it) Procedimento per la reidratazione rapida di legumi e simili, nonche'apparecchiatura per la reidratazione rapida ed in continuov di legumi e simili.
IT8419215A0 (it) Procedimento per la purificazione di soluzioni contenenti fruttosio 2-6 difosfato (f-2,6-p2) e utilizzazione del composto cosi'ottenuto in terapia.
IT8348872A0 (it) Procedimento per la determinazione dello stato di virulenza o di latenza del virus dell'herpes nei tessuti cellulari
ZA887365B (en) Adheson variants
ATE30238T1 (de) N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer.
EP0341318A4 (en) Novel platinum (ii) complex, process for preparing the same, and therapeutic agent for malignant tumor
EP0136093A3 (fr) Facteurs anti-cancereux